MaxCyte, Inc (MXCT) Files up to $100M IPO
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/17/2026
- Wall Street tumbles as worries about AI trade and high oil prices weigh
- Oil touches $110 a barrel for first time since May on Middle East, Russia supply fears
- Stay risk-off as higher real yields and AI volatility threaten stocks: BofA
- Apple’s first foldable iPhone sells out within minutes as preorders begin
- CoreWeave bond rout tests market's math on AI buildout
Tweet
Share
E-mailGet Alerts MXCT Hot Sheet
Join SI Premium – FREE
MaxCyte, Inc (NASDAQ: MXCT) has files an up to $100,000,000 IPO.
The company describes itself as: "We are a leading commercial cell engineering company focused on providing enabling platform technologies to advance innovative cell-based research as well as next-generation cell therapeutic discovery, development and commercialization."
Cowen, Stifel and William Blair will serve as underwriters.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- City Therapeutics prices IPO at $18 per share, raising $200M
- Stifel invests in Meow, plans digital banking platform launch
- Hyperscale Data plans to take AI subsidiary askROI public in 2027
Create E-mail Alert Related Categories
Corporate News, IPOsRelated Entities
Stifel, William Blair, Cowen & Co, IPOSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
